Use of cytokines in clozapine-induced agranulocytosis

Canadian Journal of Psychiatry

Volumn 41, Issue 5, 1996, Pages 280-284

  Chin Yee, Ian ^a,b   Butler, Kalyna Bezchlibnyk ^c   Wong, Lillian ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

clozapine; G CSF; neutropenia; review

Indexed keywords

CLOZAPINE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGRANULOCYTOSIS; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALE; NEUTROPENIA; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 8944238476     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674379604100504     Document Type: Article

References (42)

1. Ereshefsky L, Watanabe MD, Tran-Johnson TK. Clozapine: an atypical antipsychotic agent. Clinical Pharmacy 1994;8:691-709.
2. Ayd FJ Jr. Clozapine 1994: clinical considerations. International Drug Therapy Newsletter 1994;29:21-8.
3. Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW. Efficacy and adverse effects of Clozapine in four elderly psychotic patients. J Clin Psychiatry 1995;56:180-5.
4. Wolk SI, Douglas CJ. Clozapine treatment of psychosis in Parkinson's disease: a report of five consecutive cases. J Clin Psychiatry 1992;53:373-6.
5. Peacock L, Gerlach J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in a system with liberal usage practices. J Clin Psychiatry 1994;55:44-9.
6. Safferman AZ, Lieberman JA, Alvir JMJ, Howard A. Rechallenge in clozapine-induced agranulocytosis. Lancet 1992;339:1296-7.
7. Kupp P, Barnes P. Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology 1989;99:118S-121S.
8. Cates M, Lusk K, Wells BG, Guthrie TC, West M. Non-leukopenic neutropenia in a patient treated with clozapine. N Engl J Med 1992;326:840-1.
9. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989;50:329-38.
10. Bodey BP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-40.
11. Crawford J, Ozer H, Stoller R, and others. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 1991;325:164-70.
12. Nemunaitis J, Rabinowe SN, Singer JW, and others. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 1991;324:1773-8.
13. Nielsen H. Recombinant human granulocyte colony-stimulating factor (fhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis. J Intern Med 1993;234:529-31.
14. Lord BI, Bronchud MH, Owens S, and others. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A 1989;86:9499-503.
15. Lord BI, Gurney H, Chang J, Thatcher N, Crowther D, Dexter TM. Haemopoietic cell kinetic in humans treated with rGM-CSF. Int J Cancer 1992;50:26-31.
16. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, and others. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74:2644-51.
17. Lamberti JS, Bellnier TJ, Schwarzkopf SB, Schneider E. Filgrastim treatment of three patients with clozapine-induced agranulocytosis. J Clin Psychiatry 1995;56:256-9.
18. Raison CL, Guze BH, Kissell RL. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor. J Clin Psychopharmacol 1994;14:285-6.
19. Teitelbaum AH, Bell AJ, Brown SL. Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis. Am J Med 1993;95:245-6.
20. Gerson SL, Gullion G, Yeh HS, Masor C. Granulocyte colony-stimulation factor for clozapine-induced agranulocytosis. Lancet 1992;340:1097.
21. Barnas C, Zwierzina H, Hummer M, Sperner-Unterweger B, Stern A, Fleischhacke WW. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. J Clin Psychiatry 1992;53:245-7.
22. Gullion G, Yeh JS. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor. J Clin Psychiatry 1994;55:401-5.
23. Ryabik BM, Nguyen VT, Mann RM, Smith JD, Lippmann SB. Clozapine-induced agranulocytosis and colony stimulating cytokines. Gen Hosp Psychiatry 1993;15:263-5.
24. Oren R, Granat E, Shtrussberg S, Matzner Y. Clozapine induced agranulocytosis treated with granulocyte macrophage colony stimulating factor. Br J Psychiatry 1993;162:686-7.
25. Weide R, Koppler H, Heymanns J, Pfluger KH, Havemann K. Successful treatment of clozapine-induced agranulocytosis with granulocyte-colony stimulating factor (G-CSF). Br J Haematol 1992;80:557-9.
26. Gerbig CB, Marks LW. The treatment of clozapine and molindone-induced agranulocytosis with granulocyte colony-stimulating factor. Ann Pharmacother 1993;27:1190-2.
27. Jakubowski AA, Souza L, Kelly F, and others. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med 1989;320:38-42.
28. Hammond WPIV, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989;320:1306-11.
29. Sprikkelman A, de Wolf J, Vellenga E. The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases. Leukemia 1994;8:2031-6.
30. Pisciotta AB, Konings SA, Ciesemier LL, Cronkite CE, Lieberman JA. On the possible mechanisms and predictability of clozapine-induced agranulocytosis. Drug Saf 1992;7(1 Suppl):33S-44S.
31. Gerson SL, Meltzer H. Mechanisms of clozapine-induced agranulocytosis. Drug Saf 1992;7(1 Suppl):17S-25S.
32. Pfister GM, Hanson OR, Roerig JL, Landbloom R, Popkin MK. Clozapine-induced agranulocytosis in a Native American: HLA typing and further support of an immune-mediated mechanism. J Clin Psychiatry 1992;53:242-4.
33. Claas FHJ, Abbott PA, Witvliet MD, d'Amaro J, Barnes PM, Krupp P. No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis. Drug Saf 1992;7(1 Suppl):3S-6S.
34. Lieberman JA, Johns CA, Kane JM, Rai K, Pisciotta AV, Saltz BL, and others. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. J Clin Psychiatry 1988;49:271-7.
35. Miles CP. Conditions predisposing to suicide: a review. J Nerv Ment Dis 1977;164:231-46.
36. Gelenberg AJ. Eosinophilia, neutropenia, and dozapine. Biological Therapies in Psychiatry 1993;16:21-2.
37. Banov MD, Tohen M, Friedberg J. High risk of eosinophilia in women treated with dozapine. J Clin Psychiatry 1993;54:466-9.
38. Thhonen J, Paanila J. Eosinophilia associated with clozapine. Lancet 1992;339:488.
39. Dale DC, Guerry D, Wewerka J, Bull J, Chusid M. Chronic neutropenia. Medicine 1979;58:128-44.
40. Pizzo PA. Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 1993;328:1323-32.
41. Nauseef WM, Maki DG. A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 1981;304:448-53.
42. Chanock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993;7:771-93.